Correlation of pap smear, cervical biopsy, and clinical follow-up with an HPV typing microarray system

Diagnostic Molecular Pathology

Volumn 17, Issue 2, 2008, Pages 107-111

  Nuovo, Gerard J ^a   Bartholomew, Deborah ^a   Jung, Woon Won ^b   Han, In Kwon ^b   Um, Taeyoung ^b   Grabarz, Donald F ^c   Lee, Duck Joo ^c   McCabe, R Tyler ^c  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b MyGene Bioscience Institute   (South Korea)

^c MyGene International Inc   (United States)

Author keywords

ASCUS; Human papillomavirus; Pap smear; SIL; Typing

Indexed keywords

ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE SEQUENCE; HUMAN; HUMAN TISSUE; INFECTION RISK; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; MIXED INFECTION; PAPANICOLAOU TEST; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SQUAMOUS CELL; UTERINE CERVIX BIOPSY; VIRUS DETECTION; VIRUS GENE; VIRUS INFECTION; VIRUS TYPING; WART VIRUS; BIOPSY; CHEMISTRY; CLASSIFICATION; COMPARATIVE STUDY; DNA MICROARRAY; DNA PROBE; GENETICS; ISOLATION AND PURIFICATION; METHODOLOGY; PAPILLOMA VIRUS; PRECANCER; REPRODUCIBILITY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VAGINA SMEAR; VIROLOGY;

VIRUS DNA;

BIOPSY; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA PROBES, HPV; DNA, VIRAL; FEMALE; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; REPRODUCIBILITY OF RESULTS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 47049094578     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/PDM.0b013e318161e4dd     Document Type: Article

References (16)

1. Nuovo GJ. Cytopathology of the Lower Female Genital Tract: an Integrated Approach. Baltimore, MD: Williams and Wilkins; 1996.
2. Hammou JC. Thin-layer cytology: identification of human papillo-mavirus by hybridization, capture and signal amplification assay using an alcoholic cell preservative medium. Acta Cytol. 2007;51: 193-196.
3. Muldrew KL, Beqaj SH, Han J, et al. Evaluation of a Digene-recommended algorithm for human papillomavirus low-positive results present in a 51retest zone51. Am J Clin Pathol. 2007;127:97-102.
4. Petignat P, Faltin DL, Bruchim I, et al. Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis. Gynecol Oncol. 2007;105:530-535.
5. Manavi M, Hudelist G, Fink-Retter A, et al. Gene profiling in Pap-cell smears of high-risk human papillomavirus- positive squamous cervical carcinoma. Gynecol Oncol. 2007;105:418-426.
6. Koliopoulos G, Arbyn M, Martin-Hirsch P, et al. Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies. Gynecol Oncol. 2007;104:232-246.
7. Kahn JA, Slap GB, Bernstein DI, et al. Personal meaning of human papillomavirus and Pap test results in adolescent and young adult women. Health Psychol. 2007;26:192-200.
8. Einstein MH, Studentsov YY, Ho GY, et al. Combined human papillomavirus DNA and human papillomavirus-like particle serologic assay to identify women at risk for high-grade cervical intraepithelial neoplasia. Int J Cancer. 2007;120:55-59.
9. Plummer M, Schiffman M, Castle PE, et al. A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. J Infect Dis. 2007;195:1582-1589.
10. Kapala J, Jang D, Patel J, et al. Pap cytopathology and the presence of high-risk human papillomavirus in SurePath liquid preservative and Digene cervical sampler specimens. J Virol Methods. 2007;142: 223-225.
11. TM Pap smears that mimic low grade SILs. Cancer Cytopath. 2003;99:75-82.
12. Menezes G, Wakely P, Nuovo GJ. Increased incidence of atypical Papanicolaou smears from ThinPreps of post menopausal women on hormone replacement therapy. Cancer Cytopathol. 2001;93:357-363.
13. Nuovo GJ, Pedemonte BA. Human papillomavirus types and recurrent genital warts. JAMA. 1990;263:1223-1226.
14. Ault KA. Effect of prophylactic human papillomavirus L1 viruslike-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomized clinical trials. Lancet. 2007;369:1861-1868.
15. Garland SM, Hernandez-Avila M, Wheeler CM, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med. 2007;356:1928-1943.
16. An HJ, Cho NH, Lee SY, et al. Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method. Cancer. 2003;97:1672-1680.